Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc Income Statement 2021–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 677.6M | 423.2M | 270.3M | 220.2M | 38.5M |
| Gross Profit | 599.9M | 362.3M | 236.9M | 197.3M | 29.4M |
| Profitability | |||||
| Operating Income | 77.2M | -45.6M | -25.2M | 9.8M | -156.6M |
| EBITDA | 78.8M | -43.9M | -22.9M | 12.2M | -154.3M |
| Net Income | 59.0M | -43.2M | 14.1M | 183.4M | -157.9M |
| Per Share Data | |||||
| EPS (diluted) | $0.75 | $-0.60 | $0.20 | $2.60 | $-2.30 |
| Shares Outstanding (dil.) | 79M | 71M | 72M | 70M | 69M |
Kiniksa Pharmaceuticals International, plc Income Statement — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KNSA's income statement history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's income statement by year and by quarter, including the growth rate.